Literature DB >> 18844802

Psychiatric nurses' attitudes to antipsychotic depots in Hong Kong and comparison with London.

M X Patel1, F K K Yeung, P M Haddad, A S David.   

Abstract

Psychiatric nurses' attitudes to depots have only been explored in the UK. We conducted a cross-sectional attitudinal study for Hong Kong psychiatric nurses and also conducted international comparisons for nurses' views about depots. A pre-existing UK questionnaire on clinicians' attitudes and knowledge regarding depots was updated for the present study. Participants were 98 psychiatric nurses who attended an academic meeting. The majority of respondents had positive views regarding their role in depot administration; most reported that they had sufficient training (84%). However, many did not feel involved in treatment decision making (60%) and other negative views were expressed including: (1) most patients always prefer to have oral (vs. depot) (80%); and (2) force is sometimes required when administering a depot (40%). Interestingly, most reported that patients' friends and family were more accepting of depot (vs. oral) (69%). When compared with a former sample of London community psychiatric nurses, Hong Kong nurses had less favourable patient-focussed attitudes (mean 56% vs. 60%, P = 0.051) and depot-specific attitudes regarding depots (mean 63% vs. 69%, P < 0.001). In conclusion, therefore, international variation exists and encompasses clinical practice aspects for both the patient and the depot formulation per se. Our participants wanted more involvement in treatment decision making.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18844802     DOI: 10.1111/j.1365-2850.2008.01306.x

Source DB:  PubMed          Journal:  J Psychiatr Ment Health Nurs        ISSN: 1351-0126            Impact factor:   2.952


  7 in total

1.  WPA guidance on how to combat stigmatization of psychiatry and psychiatrists.

Authors:  Norman Sartorius; Wolfgang Gaebel; Helen-Rose Cleveland; Heather Stuart; Tsuyoshi Akiyama; Julio Arboleda-Flórez; Anja E Baumann; Oye Gureje; Miguel R Jorge; Marianne Kastrup; Yuriko Suzuki; Allan Tasman
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

2.  Attitude and preferences towards oral and long-acting injectable antipsychotics in patients with psychosis in KwaZulu-Natal, South Africa.

Authors:  Krishanand R Roopun; Andrew Tomita; Saeeda Paruk
Journal:  S Afr J Psychiatr       Date:  2020-07-27       Impact factor: 1.550

3.  The knowledge and attitudes of psychiatrists towards antipsychotic long-acting injections in Nigeria.

Authors:  Bawo O James; Joyce O Omoaregba; Kingsley M Okonoda; Edebi U Otefe; Maxine X Patel
Journal:  Ther Adv Psychopharmacol       Date:  2012-10

4.  Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection.

Authors:  Heidi J Wehring; Sheryl Thedford; Maju Koola; Deanna L Kelly
Journal:  J Cent Nerv Syst Dis       Date:  2011-06-01

5.  Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence.

Authors:  William Ak-Lam Lo; Daniel Ki-Yan Mak; Michael Ming-Cheuk Wong; Oi-Wah Chan; Eileena Mo-Ching Chui; Dicky Wai-Sau Chung; Glendy Suk-Han Ip; Ka-Shing Lau; Che-Kin Lee; Jolene Mui; Ka-Lok Tam; Samson Tse; Kwong-Lui Wong
Journal:  CNS Neurosci Ther       Date:  2021-03       Impact factor: 5.243

6.  Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection.

Authors:  Leslie Citrome
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711

7.  Discrepancy in Taiwanese psychiatrists' preferences for long-acting injectable antipsychotics across facilities: a nationwide questionnaire survey.

Authors:  Chun-Hao Liu; Po-Hsin Tsai; Ching-Yen Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2018-02-01       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.